Abstract
Molecular diagnostic tests are now used for a wide range of applications,
including:
- Human clinical molecular diagnostic testing
- Veterinary molecular diagnostic testing
- Identity testing
- Forensic testing
- Histocompatibility testing
Within these broad disease areas, molecular diagnostics tests have a wide
range of applications, including:
- Identification of individuals who are at increased risk of developing
certain disorders
- Screening apparently healthy populations
- Diagnosis
- Determining prognosis, such as with cancer
- Personalized medicine applications, including pharmacogenetic tests such
as drug metabolism tests to avoid adverse drug effects and companion
diagnostics to identify patients who will respond to a specific drug
- Monitoring response to therapy
Molecular Diagnostics: A Rapidly Shifting Commercial and Technology
Landscape focuses on human clinical molecular diagnostics. Even within
this field, molecular diagnostics is being applied to a wide range of diseases
and applications. The first molecular diagnostics tests to reach the market
were for infectious diseases, and this remains the largest segment of the
molecular diagnostics market. Molecular oncology tests have been emerging as a
second significant-and rapidly growing-market segment. Molecular diagnostics
is also starting to emerge as an important tool for inherited disorders,
cardiovascular disorders, and other disease areas.
This report provides a thorough discussion of the many companies involved in
molecular diagnostics and their commercial products either on the market or in
development for these applications. Molecular diagnostics has emerged as a
significant segment of the overall clinical diagnostics market. Overall, the
molecular diagnostics market is growing rapidly, although some segments are
growing more rapidly than others. This report provides an overview of the
molecular diagnostics market, and discusses many of the trends in this
market-including factors that are driving the growth.
This report also includes results from a Web survey of individuals involved in
molecular diagnostics research, development, and use. More than 250 people
responded to the survey, pointing out in a question what they think will be
the biggest growth areas over the next 5 years:
As molecular diagnostics moves into the future, companies in this market will
face a number of challenges. Selected examples of the challenges are
discussed. The molecular diagnostics market is changing rapidly and is
becoming highly competitive. The market shows considerable promise for new
tests to improve the diagnosis and treatment of a wide range of diseases and
disorders.
| 
View Cart
